EP Plenary session - Deteriorating situation in Gaza following the non-extension of the ceasefire

EP Plenary session - Clean Industrial Deal

EP Plenary session - White paper on the future of European defence

EP Plenary session - Presentation of the proposal on Critical Medicines Act (CMA)

EP Plenary session - European Council meetings and European Security

EP Plenary session - US withdrawal from the Paris Climate Agreement, the World Health Organisation and the suspension of US development and humanitarian aid

EP Plenary session - US AI chip export restrictions: a challenge to European AI development and economic resilience

EP Plenary session - Escalation of violence in the eastern Democratic Republic of the Congo

EP Plenary session - Wider comprehensive EU-Middle East Strategy

EP Plenary session - Uniting Europe against actors hostile to the EU: time to strengthen our security and defence

EP Plenary session - Geopolitical and economic implications for the transatlantic relations under the new Trump administration

EP Plenary session - The need to enforce the Digital Services Act to protect democracy on social media platforms against foreign interference and biased algorithms

EP Plenary session - Ceasefire in Gaza - the urgent need to release the hostages, to end the humanitarian crisis in Gaza and to pave the way for a two-state solution

EP Plenary session - The need to ensure swift action and transparency on corruption allegations in the public sector to protect democratic integrity

EP Plenary session - Tackling abusive subcontracting and labour market intermediaries

EP Plenary session - Use of rape as weapon of war, in particular in the Democratic Republic of Congo and Sudan

EP Plenary session - Misinformation and disinformation on social media platforms, such as TikTok, and related risks to the integrity of elections in Europe

EP Plenary session - Ousting of the Syrian regime, its geopolitical implications and the humanitarian situation in the region

EP Conference of Presidents meets the upcoming Belgian Presidency - Family Photo with the Belgian Federal Parliament

EP Conference of Presidents meets the upcoming Belgian Presidency - Family Photo with the Belgian Government

Press seminar with journalists of Ouest France and 20 Minutes

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate proposal to the WTO to waive intellectual property rights for COVID-19 vaccines, a move backed by the US administration. Extracts from the debate: statements by Augusto SANTOS SILVA, Portuguese Minister of State for Foreign Affairs, Valdis DOMBROVSKIS, Executive Vice-President of the EC in charge of an Economy that works for People, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Dacian CIOLOŞ (Renew, RO), Tilly METZ (Greens/EFA, LU), Marc BOTENGA (The Left, BE), and Gilles LEBRETON (ID, FR).

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

During the plenary session of the European Parliament in Brussels (17-20 May 2021), MEPs debate on the Impacts of EU rules on the free movements of workers and services (intra-EU labour mobility as a tool to match labour market needs and skills).

Impacts of EU rules on the free movements of workers and services: MEPs debate

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on European Defence Fund.

European Defence Fund: MEPs debate

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate with Mairead MCGUINNESS, European Commissioner for financial services, on COVID-19 pandemic situation in Latin America.

Debates on cases of breaches of human rights, democracy and the rule of law: COVID-19 pandemic situation in Latin America

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on justice programme 2021-2027.

Justice programme 2021-2027: MEPs debate (continuation)

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on research and innovation. Opening statements by the rapporteurs Marc BOTENGA - Establishing Horizon Europe – laying down its rules for participation and dissemination; Christian EHLER (EPP, DE) - Specific Programme implementing Horizon Europe – the Framework Programme for Research and Innovation; Marisa MATIAS (The Left, PT) - European Institute of Innovation and Technology; Maria da Graça CARVALHO (EPP, PT) - Strategic Innovation Agenda of the European Institute of Innovation and Technology; and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth. This transcription speech is the result of an automatic process. Check against delivery.

Joint debate on research and innovation: opening statements by the rapporteurs and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth

During the plenary session (24-25 March 2021) in the European Parliament in Brussels, MEPs debate on a new EU-Africa Strategy - a partnership for sustainable and inclusive development.

A new EU-Africa Strategy - a partnership for sustainable and inclusive development: MEPs debate

During the plenary session, MEPs debate and cast their final vote on the €5.1 billion EU4Health programme for 2021-2027. The programme aims to make EU health systems more resilient, address cross-border health threats and make medicines and medical devices more available, accessible and affordable. Statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Jytte GUTELAND (S&D, SE), Luisa REGIMENTI (ID, IT), Joanna Maria KOPCIŃSKA (ECR, PL), Frédérique RIES (Renew, BE), Marc BOTENGA (The Left, BE) and Cristian-Silviu BUŞOI (EPP, RO), Rapporteur.

EU4Health Programme: extracts from the debate and the vote and statement by Cristian-Silviu BUŞOI (EPP, RO)

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy.

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 1)

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 1/3

EU global strategy on COVID-19 vaccinations: MEPs debate 1/3

During the plenary session of the European Parliament in Brussels (14-18 December 2020), MEPs debate future relations between the European Union and the United Kingdom. MEPs debate (part 2)

Future relations between the EU and the UK: MEPs debate (part 2)

During the plenary session (14-18 December 2020), mainly in Brussels, MEPs debate an EU strategy for COVID-19 vaccinations that addresses challenges inside and outside the EU. MEPs debate

Preparation of an EU Strategy on COVID-19 vaccination, including its external dimension: MEPs debate

During the remote plenary session (23-26/11/2020) of the European Parliament in Brussels, MEPs debate on a pharmaceutical strategy for Europe in the framework of the Covid-19 outbreak with Stella KYRIAKIDES, European Commissioner for Health and Food Safety. MEPs statements by Dolors MONTSERRAT (EPP, ES), Heléne FRITZON (S&D, SE), Kim VAN SPARRENTAK (Greens/EFA, NL), Frédérique RIES (RE, BE), Marc BOTENGA (GUE/NGL, BE).

Pharmaceutical strategy for Europe: extracts from the debate

During the plenary session of the European Parliament in Brussels (19-23 October 2020), MEPs debate. EU measures to mitigate social and economic impact of Covid-19. MEPs debate

Plenary session: EU measures to mitigate social and economic impact of Covid-19. MEPs debate

Public Hearing of Members of the Committee on the Environment, Public Health and Food Safety and the EP Committee on Industry, Research and Energy with Thomas TRIOMPHE, Executive Vice President, Sanofi Pasteur, Jean STEPHENNE, Chairman of the Supervisory Board, accompanied by Pierre Kemula, Chief Financial Officer, CureVac, Fergus SWEENEY, Head of Clinical Studies and Manufacturing Task Force, European Medicines Agency, Professor Robin SHATTOCK, Faculty of Medicine, Department of Infectious Disease, Imperial College London, Dr Sidney WONG, Director, Médecins Sans Frontières Access Campaign, Magdalena RODRIGUEZ de AZERO, Executive Director, Vaccines Europe, European Federation of Pharmaceutical Industries and Associations. Part 1 of 2 Q&A with ENVI and ITRE Members.

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.

81 results